Immunoglobulin variable gene analysis of human autoantibodies reveals antigen‐driven immune response to glutamate decarboxylase in type 1 diabetes mellitus
- 1 June 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (6), 1703-1712
- https://doi.org/10.1002/eji.1830250633
Abstract
Insulin-dependent (type 1) diabetes mellitus is an organ-specific autoimmune disease frequently associated with an islet-specific humoral autoimmune response. The role of islet cell autoantibodies in the disease process is unclear; in particular, it is not known whether they are a non-specific side effect of islet cell destruction or play a role in the autoimmune network leading to type 1 diabetes. Here we report the immunoglobulin gene usage and somatic mutation rates of a panel of seven human monoclonal islet cell autoantibodies (MICA 1–7) directed towards the major islet cell autoantigen glutamate decarboxylase (GAD). These autoantibodies were produced from cells from two patients with newly diagnosed type 1 diabetes. VH1, VH4 and Vλ2 gene segments were frequently used in the MICA, but no correlation between V gene usage and epitope recognition was found. The nonrandom ratio of replacement versus silent mutations in the variable gene region, an accumulation of replacement mutations in the complementarity determining regions, which confer antigen binding, and the high relative avidity for GAD observed for MICA 1, 3, 4, and 6, suggested that the immune response to GAD is driven by the antigen. In contrast, MICA 2, 5, and 7, revealing a lower affinity for antigen, have accumulated a large number of silent mutations. These latter antibodies may, therefore, be characteristic for later stages of the chronic autoimmune disease. Our results argue in favor of an antigen-driven autoantibody response to islets in human type 1 diabetes. They suggest that GAD is an important target of autoimmunity associated with type 1 diabetes.Keywords
This publication has 48 references indexed in Scilit:
- Molecular analysis of the human immunoglobulin V lambda II gene family.JCI Insight, 1994
- The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacementImmunology Today, 1994
- Discriminating intrinsic and actigen-selected mutational hotspots in immunoglobulin V genesImmunology Today, 1993
- The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loopsJournal of Molecular Biology, 1992
- A systematic approach to defining the germline gene counterparts of a mutated autoantibody from a patient with rheumatoid arthritisArthritis & Rheumatism, 1992
- Structure and expression of human germline VH transcripts.The Journal of Experimental Medicine, 1991
- Stable Expression and Somatic Hypermutation of Antibody V Regions in B-Cell Developmental PathwaysAnnual Review of Immunology, 1989
- Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.The Journal of Experimental Medicine, 1987
- Human immunoglobulin D segments encoded in tandem multigenic familiesNature, 1981
- Evolutionary nucleotide replacements in DNANature, 1979